.jpg)
Accelerating Biologics Discovery & Development Through Transformative Technologies & Overcoming Strategic Challenges
A concise report featuring insights from the prominent thought leaders of Biologics 2024
Top R&D Stories of 2023
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Peptide Chemistry
New peptide with hope of treating triple-negative breast cancer
The preclinical peptide could unlock much needed treatment options for patients with triple-negative breast cancer.
Bioanalysis
Overcoming the Hurdles: Navigating the Challenges of Bioconjugate Development
Bioconjugate development, exemplified by ADCs such as T-DM1 and Mylotarg, tackles issues like stability and specificity, benefiting from innovative solutions and services to enhance therapeutic precision in biologics.
Oligo Chemistry
New Approach to Oligo-Peptide Synthesis from Novo and Aarhus University
The collaboration could unlock the more cost-effective synthesis of oligonucleotide-peptide conjugates.
Antibody & Protein Engineering
The Current Landscape of ADC Approvals and Market Trends: Q&A With Mahendra Deonarain, CEO of Antikor Biopharma
While a recent spike in ADC approvals may not last forever, Antikor Biopharma’s Mahendra Deonarain asserts that antibody-drug conjugates are here to stay.
Antibody & Protein Engineering
Introducing the Development and Clinical Landscape of Bi and Multispecific Antibodies
While bispecific antibodies target two specific entities, multispecific antibodies can target more than two. The use of these engineered antibodies offers the potential for enhanced therapeutic strategies by simultaneously addressing multiple aspects of a disease.
Antibody & Protein Engineering
Cytokines and Immunocytokines in Therapeutic Approaches
Advancements in cytokine understanding and synthetic immunology enable precise immune modulation, particularly in cancer treatment. However, challenges like short half-lives and side effects impact their wider clinical application.
Antibody & Protein Engineering
Post-Event Proceedings - Biologics 2023
Concise and insightful summaries of presentations delivered by prominent thought leaders at Biologics 2023
Antibody & Protein Engineering
Multispecific Antibody Development: Interview with Yue Liu, President and Founder of Ab Therapeutics
Discussing using a computational drug discovery platform for the development of multispecific antibody therapeutics.
Strengthening Preparedness for the Next Pandemic: Interview with Ramin Sabet-Azad, CMC Lead, CEPI
How do we prepare for the next pandemic?
Antibody & Protein Engineering
Handbook for Stem Cell Research
This whitepaper by Sino Biological discusses the different types of stem cells based on their origin and potential, as well as the factors that direct their differentiation toward specific lineages or cell types.
Vaccine Production for Better Global Access
How were the COVID-19 vaccines developed so fast? And why were some countries left behind?